Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Biopharmaceutical Production and Development Unit (BP&DU)

The Biopharmaceutical Production and Development Unit (BP&DU) supports research-associated topics:

Group 2022 more

Group in 2022

  • Large Scale production of purified parvovirus (vector) stocks for preclinical applications or basic research
  • Development and optimization of new production, purification and analytic methods with the aim to establish working protocols for GMP-production of virus (vector) stocks necessary for clinical applications and possible market release.
  • Large scale (up to 5 Liter) production and purification of parasites non GMP- DNA
  • Divers immunological- biological- and molecular-biological assays (e.g. ELISA, potency, qPCR, endotoxin, stability, deactivation) with standardized SOPs
  • Consulting and technical support for production-related inquiries
  • Accompanying research in two ParvOryx clinical trials with patient tumor and shedding analysis (see: Research - Treat (dkfz.de))
  • Stability studies for possible drug candidates
  • In the establishment of GMP-produced parvovirus, the unit plays a pivotal role in the interaction with various organizations involved in the approval and application of procedures for virus (vector) production under GMP and GLP-conditions. Cooperations with GMP company (IDT Biologika GmbH) and GLP companies (Biogenes GmbH, Eurofins GmbH, Labor Enders & Kollegen)

Focus of the group lies in:

  • Virus production upstream optimization concerning virus yield and concentration
  • Downstream optimization according to impurity profile (empty virus particles, protein, DNA)
  • Qualified and validated analysis (quantity and quality)
  • Good process control
  • Process development including upscaling
  • Safety assessment (i.e. establishment of optimal deactivation protocols)
  • Consideration of ecological and economical aspects
  • Statistical experiment planning using Design of Experiment approach

Methods-Portfolio

Upstream process:

  • Micro and Macrocarrier up to 2.5 Liters for adherent cells
  • Suspension (shaked or stirred) Bacteria and Parasites cultures up to 5 L
  • Production in 10-layer Cell factories (6360 cm², Corning) or fixed bed bioreactor (4 m²) iCellis nano (Pall) For detailed description see Leuchs et al 2016 and Wohlfarth et al 2021

© dkfz.de

Downstream process:

  • Clarification (centrifugation, filtration with diverse filters up to 0.2µm)
  • Chromatographic purification with ÄKTApure (Cytiva). For H-1PV purification see Leuchs et al 2017
  • Stability testing as well as establishment of optimal deactivation protocol of H-1PV in regard to regulatory requirements
  • Sterile filtration and final Formulation

Specific qualitative and quantitative Analysis:

  • Metabolite analysis (Glucose, Lactate, Ammonia, LDH, etc.) with CEDEX Bio analyzer (Roche)
  • Cell and cell cycle characterization with Nucleocounter (Chemometec)
  • Photometric, fluorometric and luminometric analytical methods with FLUOstar Omega (BMG Labtech) for e.g. ELISA, immunoassays, protein-, DNA analysis

to top
powered by webEdition CMS